Telmisartan
Telmisartan tablets, USP are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.
United States
$11
per month
India
$0
per month
You save
−97%save $11/mo · 97% cheaper
1.3M US scripts/yr$14.4M potential annual savings$14.8M US spend/yr
Drag to rotate · 3D structureC33H30N4O2
SMILES: CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
Compare the price
US price$11per month
India price$1per month
You save$1194% less
Based on 30 units per month. US $0.38 vs India $0.02 per unit.
Total over 1 periodSave $11$11 → $1
The bigger picture
Telmisartan is filled about 1.3M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$14.8M
If sourced from India
$428.2K
Potential annual savings
$14.4M
−97%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.